Øystein Bruserud

Disease‐stabilizing treatment with all‐trans retinoic acid and valproic acid in acute myeloid leukemia: Serum hsp70 and hsp90 levels and serum cytokine profiles are determined by the disease, patient age, and anti‐leukemic treatment

Hanne Fredly, Håkon Reikvam, Bjørn Tore Gjertsen et al. · American Journal of Hematology · 2012 · 42 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

CD34 expression in native human acute myelogenous leukemia blasts: Differences in CD34 membrane molecule expression are associated with different gene expression profiles

Anne M. Øyan, Trond Hellem Bø, Inge Jonassen et al. · Cytometry Part B Clinical Cytometry · 2005 · 35 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Acute Myelogenous Leukemia Blasts as Accessory Cells during in Vitro T Lymphocyte Activation

Øystein Bruserud, Elling Ulvestad · Cellular Immunology · 2000 · 24 citations

Life Sciences, Hematology, Immunology +11

Serum concentrations of tumour necrosis factor-α during chemotherapy-induced leukopenia in patients with acute leukaemia and bacterial infections

Øystein Bruserud, Jann Bergheim, Faud Victor Shammas et al. · Leukemia Research · 1994 · 15 citations

Medicine, Hematology, Oncology +9

Effects of dipyridamole and R-verapamil on in vitro proliferation of blast cells from patients with acute myelogenous leukaemia

Øystein Bruserud, Graham Pawelec · Leukemia Research · 1993 · 10 citations

Medicine, Pharmacology, Chemotherapy +4